Log in to save to my catalogue

(S)-citalopram influences amygdala modulation in healthy subjects: a randomized placebo-controlled d...

(S)-citalopram influences amygdala modulation in healthy subjects: a randomized placebo-controlled d...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1677940305

(S)-citalopram influences amygdala modulation in healthy subjects: a randomized placebo-controlled double-blind fMRI study using dynamic causal modeling

About this item

Full title

(S)-citalopram influences amygdala modulation in healthy subjects: a randomized placebo-controlled double-blind fMRI study using dynamic causal modeling

Publisher

United States: Elsevier Inc

Journal title

NeuroImage (Orlando, Fla.), 2015-03, Vol.108, p.243-250

Language

English

Formats

Publication information

Publisher

United States: Elsevier Inc

More information

Scope and Contents

Contents

Citalopram and Escitalopram are gold standard pharmaceutical treatment options for affective, anxiety, and other psychiatric disorders. However, their neurophysiologic function on cortico-limbic circuits is incompletely characterized. Here we studied the neuropharmacological influence of Citalopram and Escitalopram on cortico-limbic regulatory proc...

Alternative Titles

Full title

(S)-citalopram influences amygdala modulation in healthy subjects: a randomized placebo-controlled double-blind fMRI study using dynamic causal modeling

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_1677940305

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1677940305

Other Identifiers

ISSN

1053-8119

E-ISSN

1095-9572

DOI

10.1016/j.neuroimage.2014.12.044

How to access this item